Metabolic syndrome
A cluster of risk factors that together raise cardiometabolic risk.
Metabolic syndrome is the name for five risk factors that tend to travel together: a large waist, raised blood pressure, raised fasting glucose, raised triglycerides and low HDL cholesterol. The 2009 joint statement that harmonised the competing definitions settled on any three of the five, with waist thresholds that differ by population rather than one global number.
It matters because the combination is worse than the sum of its parts, raising the risk of type 2 diabetes, heart disease and stroke more than any single component would predict. It is also common, and it is silent: nothing about it hurts until something else does.
Underneath the list sit two related processes, insulin resistance and excess visceral fat. That is why the five markers cluster in the first place, and why interventions that shift those two tend to move several of the markers at once rather than one at a time.
The diagnosis is deliberately unglamorous to make: a tape measure, a blood pressure cuff, and a routine blood panel. There is no scan and no proprietary test involved, and a private panel that adds thirty markers does not improve on it.
It responds well, which is the encouraging half. Weight loss, regular exercise of both kinds, better diet quality and sleep move these numbers, and where medication is warranted it works alongside those rather than instead of them. Improvement usually shows up first in triglycerides and blood pressure.
One caution about the label itself: some clinicians argue it adds little to treating each risk factor on its merits, since nobody is prescribed anything for the syndrome as such. Treat it as a useful pattern to notice in yourself rather than as a diagnosis to collect.
In practice, our waist to height ratio calculator covers the cheapest component, and the metabolic fitness index scores the cluster together from the numbers you already have.
Sources
- Alberti KGMM, et al. Harmonizing the metabolic syndrome: a joint interim statement of the IDF Task Force on Epidemiology and Prevention; NHLBI; AHA; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009;120:1640-1645
- Browning LM, Hsieh SD, Ashwell M. A systematic review of waist-to-height ratio as a screening tool for the prediction of cardiovascular disease and diabetes: 0.5 could be a suitable global boundary value. Nutr Res Rev 2010;23:247-269